Defined-outcome structure: TMAR seeks to match the price return of the EEM (iShares MSCI Emerging Markets ETF), buffering the first 10% of losses while capping upside at 29.55% (before fees) over each annual outcome period. Asia-heavy, tech-led exposure: Taiwan, South Korea, China, and India dominate the underlying index, with information technology representing roughly 40% of portfolio exposure — making the artificial intelligence and semiconductor cycle the single largest structural driver.
Macro drivers: ALLW is engineered to weather both growth and inflation surprises, making its forward path highly sensitive to shifts in Federal Reserve policy and global inflation trends. Asset class outlook: The fund blends global equities, nominal bonds, inflation-linked bonds, commodities, and cash, so its trajectory hinges on the interaction of equity momentum, bond yields, and commodity cycles.
Macro driver: XBNB's trajectory is tied to broader crypto-market liquidity, which remains sensitive to Federal Reserve interest-rate policy and overall risk appetite. Structural exposure: The fund seeks 2x daily leveraged exposure to BNB, the native token of the BNB Chain ecosystem, amplifying both upside and downside on a single-day basis.
WDCX is the Tradr 2X Long WDC Daily ETF, a leveraged single-stock exchange-traded fund that seeks 200% of the daily return of Western Digital ( WDC ), before fees and expenses. Because WDCX is a daily-reset leveraged ETF, no individual analyst price targets exist for the fund itself; the $8 objective discussed here is a technical recovery level from public market commentary, not an analyst consensus.
The $13 objective is not an analyst consensus — no sell-side firm publishes a formal price target on this leveraged single-stock ETF. It reflects a technical recovery zone near the fund's late-October trading range. The latest verified price is about $9.37 (market) with a net asset value near $9.33, according to issuer data from Nov. 11, 2026; reaching $13 would require roughly a 39% gain .
PILL is the Direxion Daily Pharmaceutical & Medical Bull 3X Shares, a leveraged exchange-traded fund (ETF) that seeks 300% of the daily return of the S&P Pharmaceuticals Select Industry Index. As an ETF with a daily-reset mandate, PILL does not carry conventional sell-side analyst price targets; the $20 objective used here comes from public discussion and technical analysis, not an analyst consensus.
The $30 central target comes from public technical and research commentary, not an analyst consensus, because the KHPI is an ETF and does not have sell-side analyst price targets. With the fund recently trading around $25.77, reaching $30 would require roughly 16% upside, a substantial move for a hedged income strategy.
The central target of $20 is drawn from public market discussion and technical analysis — notably the fund's first major resistance zone near $20.60 — not from an analyst consensus, since ETFs do not carry single-name analyst price targets. With the ETF trading around $13.73 in mid-November 2026, reaching $20 would require roughly 46% upside.
The $13 price target comes from public discussion and technical milestones, not a sell-side analyst consensus, because AMYY is an ETF with no meaningful analyst price-target coverage. AMYY has recently traded near $11.59, close to its 52-week low of roughly $11.50 and far below its 52-week high of about $25.14.
The central target of $55 is not an analyst-derived figure; it comes from public discussion and technical milestones, chiefly a return toward UCC's 52-week high near $57. With UCC trading around $47, reaching $55 would require a gain of roughly 17%, a substantial move for a leveraged fund.
The central target of $30 is the fund's published upside cap of $29.92 for the current outcome period (March 23, 2026 to March 19, 2027), rounded to a clean figure. Because TMAR is an ETF, it carries no analyst price targets; the $30 level reflects the fund's option-based cap, not a Wall Street consensus.
ALLW is an exchange-traded fund, not an individual stock, so it does not carry sell-side analyst price targets; the $32 objective used here is a forward-looking technical milestone, not an analyst consensus. The ALLW fund recently traded around $29, putting the $32 target roughly 10% above the latest market price.
XBNB is the Teucrium xETFs 2x Long Daily BNB ETF, an actively managed fund that seeks roughly two times (2x) the daily price performance of BNB (Binance Coin), before fees and expenses. The $41 target is not an analyst consensus. No credible analyst price targets exist for this ETF, so the figure comes from public technical-model discussion projecting roughly $41 over a multi-month horizon.
WDCX fell roughly 58% over the trailing 30 days, declining from about $11.50 to $4.81 as losses in its single underlying stock were amplified. The fund is a leveraged ETF (exchange-traded fund) designed to deliver 200% (2x) of the daily return of Western Digital (WDC) common shares, reset each trading day.
PILL declined roughly 13% over the trailing 30 days as weakness across U.S. pharmaceutical stocks was amplified by the fund's 3x daily leverage. The broader three-month trend is steeper, with PILL down approximately 43% amid sustained pressure in the pharmaceuticals sub-industry.
GraniteShares YieldBOOST AMD ETF (AMYY) fell roughly 12% over the trailing 30 days, deepening a decline of about 21% over the past quarter. The fund's strategy is tied entirely to Advanced Micro Devices ( AMD ), whose shares dropped about 20% during the same month.
KHPI is an actively managed derivative income ETF (exchange-traded fund) that pairs full S&P 500 equity exposure with an options overlay that sells call options and buys protective puts. The portfolio is dominated by a single holding — the Vanguard S&P 500 ETF ( VOO ) — which represents essentially all of its net assets.
KLAG declined roughly 45% over the last 30 days, closely tracking a sharp selloff in its underlying single holding, KLAC . The drop reflects a broad semiconductor-equipment downturn rather than company-specific fundamental weakness.
UCC seeks to deliver 2x (two times) the daily performance of the Dow Jones U.S. Consumer Services Index, a benchmark representing the consumer discretionary segment of the S&P 500. The fund is heavily concentrated in its largest names, with Amazon and Tesla together accounting for roughly a quarter of portfolio exposure.
TMAR is a defined-outcome, "buffered" ETF (exchange-traded fund) that uses FLEX Options to track the price return of the iShares MSCI Emerging Markets ETF ( EEM ) up to a cap, while seeking to cushion the first 10% of losses. The fund provides indirect exposure to large- and mid-cap emerging market equities, with information technology and financials the dominant sectors and China, India, Taiwan, and South Korea the largest country weights.